Drug
Edaravone
Edaravone: highest development phase Post-Market, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Edaravone NCT00200356 | Post-Market | Cerebral Infarction |
Latest
No recent events.
Follow Edaravone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.